The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
3',4'-difluoro-N-(4'-fluoro-6-((R)-pyrrolidin-3-yloxy)biphenyl-3-yl)-6-((S)-pyrrolidin-3-yloxy)biphenyl-3-carboxamide dihydrochloride ID: ALA4584851
PubChem CID: 155562257
Max Phase: Preclinical
Molecular Formula: C33H32Cl2F3N3O3
Molecular Weight: 573.62
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: Cl.Cl.O=C(Nc1ccc(O[C@@H]2CCNC2)c(-c2ccc(F)cc2)c1)c1ccc(O[C@H]2CCNC2)c(-c2ccc(F)c(F)c2)c1
Standard InChI: InChI=1S/C33H30F3N3O3.2ClH/c34-23-5-1-20(2-6-23)28-17-24(7-10-32(28)42-26-12-14-38-19-26)39-33(40)22-4-9-31(41-25-11-13-37-18-25)27(15-22)21-3-8-29(35)30(36)16-21;;/h1-10,15-17,25-26,37-38H,11-14,18-19H2,(H,39,40);2*1H/t25-,26+;;/m0../s1
Standard InChI Key: XSSFZCLVXBYISR-WDBMUBOCSA-N
Molfile:
RDKit 2D
44 47 0 0 0 0 0 0 0 0999 V2000
10.9256 -3.0628 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
4.7822 -9.0564 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4979 -10.2948 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.9298 -9.4633 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7819 -4.1084 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3589 -10.2842 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2110 -8.2302 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1697 -1.8794 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6448 -10.6991 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4978 -6.9991 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.2140 -9.0531 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6379 -9.0486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7827 -8.2321 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0689 -5.3485 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7593 -2.5952 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.9771 -2.0486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6969 -11.5322 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7839 -10.7082 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3132 -3.2066 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5002 -5.3480 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4976 -7.8241 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4970 -9.4698 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4769 -10.9906 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8902 -11.7047 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.9298 -10.2890 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4973 -4.5174 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7837 -5.7613 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7835 -6.5864 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0753 -10.6934 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
4.7794 -3.2833 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.0700 -4.5211 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3535 -9.4549 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0689 -6.9988 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.0282 -10.3769 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2102 -4.1023 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0637 -2.8729 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9229 -4.5120 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6353 -4.0976 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6327 -3.2718 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9118 -2.8621 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2023 -3.2789 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3384 -2.8596 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
8.3443 -4.5039 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
12.3428 -9.4171 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
12 4 1 0
34 23 1 0
8 15 1 0
23 24 1 0
5 31 1 0
4 25 2 0
21 13 2 0
5 30 1 0
26 35 1 0
22 3 1 0
16 8 1 0
14 27 1 0
24 17 1 0
32 12 2 0
25 9 1 0
36 30 1 6
11 7 2 0
7 21 1 0
28 10 1 0
15 19 1 0
6 29 1 0
2 22 2 0
6 32 1 0
22 11 1 0
10 21 1 0
11 4 1 0
9 6 2 0
26 5 2 0
13 2 1 0
17 18 1 0
18 34 1 0
19 36 1 0
36 16 1 0
20 26 1 0
28 33 2 0
27 20 2 0
31 14 2 0
18 3 1 1
27 28 1 0
35 37 2 0
37 38 1 0
38 39 2 0
39 40 1 0
40 41 2 0
41 35 1 0
39 42 1 0
38 43 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 573.62Molecular Weight (Monoisotopic): 573.2239AlogP: 6.17#Rotatable Bonds: 8Polar Surface Area: 71.62Molecular Species: BASEHBA: 5HBD: 3#RO5 Violations: 2HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski): 2CX Acidic pKa: ┄CX Basic pKa: 10.58CX LogP: 5.64CX LogD: 0.19Aromatic Rings: 4Heavy Atoms: 42QED Weighted: 0.24Np Likeness Score: -0.91
References 1. (2018) Substituted n-([1,1''-biphenyl]-3-yl)-[1,1''-biphenyl]-3-carboxamide analogs as inhibitors for beta-catenin/b-cell lymphoma 9 interactions,